CFTR c.4046G>A ;(p.G1349D)

Variant ID: 7-117304824-G-A

NM_000492.3(CFTR):c.4046G>A;(p.G1349D)

This variant was identified in 164 publications

View GRCh38 version.




Publications:


Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis.

Frontiers In Pharmacology
Xie, Shuying S; Wei, Shizhang S; Ma, Xiao X; Wang, Ruilin R; He, Tingting T; Zhang, Zhao Z; Yang, Ju J; Wang, Jiawei J; Chang, Lei L; Jing, Manyi M; Li, Haotian H; Zhou, Xuelin X; Zhao, Yanling Y
Publication Date: 2023

Variant appearance in text: CFTR: G1349D
PubMed Link: 37324459
Variant Present in the following documents:
  • Main text
  • fphar-14-1173542.pdf
View BVdb publication page



Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis.

Pharmaceutics
Han, Xiaoxuan X; Li, Danni D; Reyes-Ortega, Felisa F; Schneider-Futschik, Elena K EK
Publication Date: 2023-05-13

Variant appearance in text: CFTR: G1349D
PubMed Link: 37242730
Variant Present in the following documents:
  • Main text
  • pharmaceutics-15-01488.pdf
View BVdb publication page



Network expansion of genetic associations defines a pleiotropy map of human cell biology.

Nature Genetics
Barrio-Hernandez, Inigo I; Schwartzentruber, Jeremy J; Shrivastava, Anjali A; Del-Toro, Noemi N; Gonzalez, Asier A; Zhang, Qian Q; Mountjoy, Edward E; Suveges, Daniel D; Ochoa, David D; Ghoussaini, Maya M; Bradley, Glyn G; Hermjakob, Henning H; Orchard, Sandra S; Dunham, Ian I; Anderson, Carl A CA; Porras, Pablo P; Beltrao, Pedro P
Publication Date: 2023-02-23

Variant appearance in text: CFTR: 4046G>A; Gly1349Asp
PubMed Link: 36823319
Variant Present in the following documents:
  • 41588_2023_1327_MOESM4_ESM.xlsx, sheet 6
View BVdb publication page



Organoid Technology and Its Role for Theratyping Applications in Cystic Fibrosis.

Children (Basel, Switzerland)
Conti, Jessica J; Sorio, Claudio C; Melotti, Paola P
Publication Date: 2022-12-20

Variant appearance in text: CFTR: G1349D
PubMed Link: 36670555
Variant Present in the following documents:
  • children-10-00004.pdf
View BVdb publication page



Role of inhaled antibiotics in the era of highly effective CFTR modulators.

European Respiratory Review : An Official Journal Of The European Respiratory Society
Elborn, J Stuart JS; Blasi, Francesco F; Burgel, Pierre-Régis PR; Peckham, Daniel D
Publication Date: 2023-03-31

Variant appearance in text: CFTR: G1349D
PubMed Link: 36631132
Variant Present in the following documents:
  • Main text
  • ERR-0154-2022.pdf
View BVdb publication page



Molecular targets for cystic fibrosis and therapeutic potential of monoclonal antibodies.

Saudi Pharmaceutical Journal : Spj : The Official Publication Of The Saudi Pharmaceutical Society
Moni, Sivakumar S SS; Al Basheer, Asmaa A
Publication Date: 2022-12

Variant appearance in text: CFTR: Gly1349Asp
PubMed Link: 36601503
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



The Exocrine Pancreas in Cystic Fibrosis in the Era of CFTR Modulation: A Mini Review.

Frontiers In Pediatrics
McKay, Isabelle R IR; Ooi, Chee Y CY
Publication Date: 2022

Variant appearance in text: CFTR: G1349D
PubMed Link: 35832587
Variant Present in the following documents:
  • Main text
  • fped-10-914790.pdf
View BVdb publication page



One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies.

Cells
Ensinck, Marjolein M MM; Carlon, Marianne S MS
Publication Date: 2022-06-08

Variant appearance in text: CFTR: 4046G>A; G1349D
PubMed Link: 35740997
Variant Present in the following documents:
  • Main text
  • cells-11-01868.pdf
View BVdb publication page



CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France.

Cells
Regard, Lucile L; Martin, Clémence C; Burnet, Espérie E; Da Silva, Jennifer J; Burgel, Pierre-Régis PR
Publication Date: 2022-05-28

Variant appearance in text: CFTR: G1349D
PubMed Link: 35681464
Variant Present in the following documents:
  • cells-11-01769.pdf
View BVdb publication page



New drugs in cystic fibrosis: what has changed in the last decade?

Therapeutic Advances In Chronic Disease
Roda, Juliana J; Pinto-Silva, Catarina C; Silva, Iris A I IAI; Maia, Carla C; Almeida, Susana S; Ferreira, Ricardo R; Oliveira, Guiomar G
Publication Date: 2022

Variant appearance in text: CFTR: G1349D
PubMed Link: 35620188
Variant Present in the following documents:
  • Main text
  • 10.1177_20406223221098136.pdf
View BVdb publication page



CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis.

Cells
Saluzzo, Francesca F; Riberi, Luca L; Messore, Barbara B; Loré, Nicola Ivan NI; Esposito, Irene I; Bignamini, Elisabetta E; De Rose, Virginia V
Publication Date: 2022-04-06

Variant appearance in text: CFTR: G1349D
PubMed Link: 35406809
Variant Present in the following documents:
  • cells-11-01243.pdf
View BVdb publication page



Pathophysiology of Lung Disease and Wound Repair in Cystic Fibrosis.

Pathophysiology : The Official Journal Of The International Society For Pathophysiology
Conese, Massimo M; Di Gioia, Sante S
Publication Date: 2021-03-10

Variant appearance in text: CFTR: G1349D
PubMed Link: 35366275
Variant Present in the following documents:
  • pathophysiology-28-00011.pdf
View BVdb publication page



CFTR bearing variant p.Phe312del exhibits function inconsistent with phenotype and negligible response to ivacaftor.

Jci Insight
Raraigh, Karen S KS; Paul, Kathleen C KC; Goralski, Jennifer L JL; Worthington, Erin N EN; Faino, Anna V AV; Sciortino, Stanley S; Wang, Yiting Y; Aksit, Melis A MA; Ling, Hua H; Osorio, Derek L DL; Onchiri, Frankline M FM; Patel, Shivani U SU; Merlo, Christian A CA; Montemayor, Kristina K; Gibson, Ronald L RL; West, Natalie E NE; Thakerar, Amita A; Bridges, Robert J RJ; Sheppard, David N DN; Sharma, Neeraj N; Cutting, Garry R GR
Publication Date: 2022-03-22

Variant appearance in text: CFTR: G1349D
PubMed Link: 35315358
Variant Present in the following documents:
  • jciinsight-7-148841-s135.pdf
  • jciinsight-7-148841.pdf
View BVdb publication page



Precision Medicine Based on CFTR Genotype for People with Cystic Fibrosis.

Pharmacogenomics And Personalized Medicine
Haq, Iram I; Almulhem, Maryam M; Soars, Simone S; Poulton, David D; Brodlie, Malcolm M
Publication Date: 2022

Variant appearance in text: CFTR: G1349D
PubMed Link: 35153502
Variant Present in the following documents:
  • Main text
  • pgpm-15-91.pdf
View BVdb publication page



Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy.

Breathe (Sheffield, England)
Tewkesbury, Daniel H DH; Robey, Rebecca C RC; Barry, Peter J PJ
Publication Date: 2021-12

Variant appearance in text: CFTR: G1349D
PubMed Link: 35035569
Variant Present in the following documents:
  • Main text
  • EDU-0112-2021.pdf
View BVdb publication page



Genetic Modifying Factors of Cystic Fibrosis Phenotype: A Challenge for Modern Medicine.

Journal Of Clinical Medicine
Butnariu, Lăcrămioara Ionela LI; Țarcă, Elena E; Cojocaru, Elena E; Rusu, Cristina C; Moisă, Ștefana Maria ȘM; Leon Constantin, Maria-Magdalena MM; Gorduza, Eusebiu Vlad EV; Trandafir, Laura Mihaela LM
Publication Date: 2021-12-13

Variant appearance in text: CFTR: G1349D
PubMed Link: 34945117
Variant Present in the following documents:
  • Main text
  • jcm-10-05821.pdf
View BVdb publication page



Genetic Modifying Factors of Cystic Fibrosis Phenotype: A Challenge for Modern Medicine.

Journal Of Clinical Medicine
Butnariu, Lăcrămioara Ionela LI; Țarcă, Elena E; Cojocaru, Elena E; Rusu, Cristina C; Moisă, Ștefana Maria ȘM; Leon Constantin, Maria-Magdalena MM; Gorduza, Eusebiu Vlad EV; Trandafir, Laura Mihaela LM
Publication Date: 2021-12-13

Variant appearance in text: CFTR: G1349D
PubMed Link: 34945117
Variant Present in the following documents:
  • Main text
  • jcm-10-05821.pdf
View BVdb publication page



A Comparative Analysis of Pricing and Reimbursement of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Europe.

Frontiers In Pharmacology
Abdallah, Khadidja K; De Boeck, Kris K; Dooms, Marc M; Simoens, Steven S
Publication Date: 2021

Variant appearance in text: CFTR: G1349D
PubMed Link: 34858177
Variant Present in the following documents:
  • fphar-12-746710.pdf
View BVdb publication page



Comprehensive Analysis of Combinatorial Pharmacological Treatments to Correct Nonsense Mutations in the CFTR Gene.

International Journal Of Molecular Sciences
Venturini, Arianna A; Borrelli, Anna A; Musante, Ilaria I; Scudieri, Paolo P; Capurro, Valeria V; Renda, Mario M; Pedemonte, Nicoletta N; Galietta, Luis J V LJV
Publication Date: 2021-11-04

Variant appearance in text: CFTR: G1349D
PubMed Link: 34769402
Variant Present in the following documents:
  • Main text
  • ijms-22-11972.pdf
View BVdb publication page



The determinants of survival among adults with cystic fibrosis-a cohort study.

Journal Of Physiological Anthropology
Durda-Masny, Magdalena M; Goździk-Spychalska, Joanna J; John, Aleksandra A; Czaiński, Wojciech W; Stróżewska, Weronika W; Pawłowska, Natalia N; Wlizło, Jolanta J; Batura-Gabryel, Halina H; Szwed, Anita A
Publication Date: 2021-11-08

Variant appearance in text: CFTR: G1349D
PubMed Link: 34749804
Variant Present in the following documents:
  • Main text
View BVdb publication page



Frequency of allele variations in the CFTR gene in a Mexican population.

Bmc Medical Genomics
Cantú-Reyna, Consuelo C; Galindo-Ramírez, Roberto R; Vázquez-Cantú, Mercedes M; Haddad-Talancón, Lorenza L; García-Muñoz, Willebaldo W
Publication Date: 2021-11-05

Variant appearance in text: rs193922525
PubMed Link: 34740355
Variant Present in the following documents:
  • 12920_2021_1111_MOESM1_ESM.xlsx, sheet 1
View BVdb publication page



A small molecule CFTR potentiator restores ATP-dependent channel gating to the cystic fibrosis mutant G551D-CFTR.

British Journal Of Pharmacology
Liu, Jia J; Berg, Allison P AP; Wang, Yiting Y; Jantarajit, Walailak W; Sutcliffe, Katy J KJ; Stevens, Edward B EB; Cao, Lishuang L; Pregel, Marko J MJ; Sheppard, David N DN
Publication Date: 2022-04

Variant appearance in text: CFTR: G1349D
PubMed Link: 34644413
Variant Present in the following documents:
  • BPH-179-1319.pdf
View BVdb publication page



State of the Art on Approved Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators and Triple-Combination Therapy.

Pharmaceuticals (Basel, Switzerland)
Meoli, Aniello A; Fainardi, Valentina V; Deolmi, Michela M; Chiopris, Giulia G; Marinelli, Francesca F; Caminiti, Caterina C; Esposito, Susanna S; Pisi, Giovanna G
Publication Date: 2021-09-15

Variant appearance in text: CFTR: G1349D
PubMed Link: 34577628
Variant Present in the following documents:
  • Main text
  • pharmaceuticals-14-00928.pdf
View BVdb publication page



Two Years of Newborn Screening for Cystic Fibrosis in North Macedonia: First Experience.

Balkan Journal Of Medical Genetics : Bjmg
Fustik, S S; Anastasovska, V V; Plaseska-Karanfilska, D D; Stamatova, A A; Spirevska, L L; Pesevska, M M; Terzikj, M M; Vujovic, M M
Publication Date: 2021-06

Variant appearance in text: CFTR: 4046G>A; G1349D
PubMed Link: 34447658
Variant Present in the following documents:
  • Main text
  • bjmg-24-041.pdf
View BVdb publication page



Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis.

International Journal Of Molecular Sciences
Harwood, Kiera H KH; McQuade, Rachel M RM; Jarnicki, Andrew A; Schneider-Futschik, Elena K EK
Publication Date: 2021-07-16

Variant appearance in text: CFTR: G1349D
PubMed Link: 34299226
Variant Present in the following documents:
  • Main text
  • ijms-22-07606.pdf
View BVdb publication page



Cystic Fibrosis Human Organs-on-a-Chip.

Micromachines
Ogden, Herbert Luke HL; Kim, Hoyeol H; Wikenheiser-Brokamp, Kathryn A KA; Naren, Anjaparavanda P AP; Mun, Kyu Shik KS
Publication Date: 2021-06-25

Variant appearance in text: CFTR: G1349D
PubMed Link: 34202364
Variant Present in the following documents:
  • Main text
  • micromachines-12-00747.pdf
View BVdb publication page



New Therapies to Correct the Cystic Fibrosis Basic Defect.

International Journal Of Molecular Sciences
Bergeron, Christelle C; Cantin, André M AM
Publication Date: 2021-06-08

Variant appearance in text: CFTR: G1349D
PubMed Link: 34201249
Variant Present in the following documents:
  • Main text
View BVdb publication page



Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization.

Pulmonary Therapy
Hubert, Dominique D; Marguet, Christophe C; Benichou, Jacques J; DeSouza, Cynthia C; Payen-Champenois, Catherine C; Kinnman, Nils N; Chandarana, Keval K; Munck, Anne A; Fajac, Isabelle I; ,
Publication Date: 2021-12

Variant appearance in text: CFTR: G1349D
PubMed Link: 34101145
Variant Present in the following documents:
  • Main text
  • 41030_2021_Article_158.pdf
View BVdb publication page



Cystic Fibrosis Lung Disease Modifiers and Their Relevance in the New Era of Precision Medicine.

Genes
Sepahzad, Afsoon A; Morris-Rosendahl, Deborah J DJ; Davies, Jane C JC
Publication Date: 2021-04-13

Variant appearance in text: CFTR: G1349D
PubMed Link: 33924524
Variant Present in the following documents:
  • Main text
View BVdb publication page



Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review.

Antibiotics (Basel, Switzerland)
Girón Moreno, Rosa María RM; García-Clemente, Marta M; Diab-Cáceres, Layla L; Martínez-Vergara, Adrián A; Martínez-García, Miguel Ángel MÁ; Gómez-Punter, Rosa Mar RM
Publication Date: 2021-04-23

Variant appearance in text: CFTR: G1349D
PubMed Link: 33922413
Variant Present in the following documents:
  • Main text
View BVdb publication page



Identification of Potential Leukocyte Biomarkers Related to Drug Recovery of CFTR: Clinical Applications in Cystic Fibrosis.

International Journal Of Molecular Sciences
Pedrazzi, Marco M; Vercellone, Silvia S; Barberis, Elettra E; Capraro, Michela M; De Tullio, Roberta R; Cresta, Federico F; Casciaro, Rosaria R; Castellani, Carlo C; Patrone, Mauro M; Marengo, Emilio E; Lecca, Paola P; Melotti, Paola P; Sorio, Claudio C; Manfredi, Marcello M; Averna, Monica M
Publication Date: 2021-04-10

Variant appearance in text: CFTR: G1349D
PubMed Link: 33920274
Variant Present in the following documents:
  • Main text
View BVdb publication page



Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.

Plos Genetics
Yu, Mullin Ho Chung MHC; Chan, Marcus Chun Yin MCY; Chung, Claudia Ching Yan CCY; Li, Andrew Wang Tat AWT; Yip, Chara Yin Wa CYW; Mak, Christopher Chun Yu CCY; Chau, Jeffrey Fong Ting JFT; Lee, Mianne M; Fung, Jasmine Lee Fong JLF; Tsang, Mandy Ho Yin MHY; Chan, Joshua Chun Ki JCK; Wong, Wilfred Hing Sang WHS; Yang, Jing J; Chui, William Chun Ming WCM; Chung, Patrick Ho Yu PHY; Yang, Wanling W; Lee, So Lun SL; Chan, Godfrey Chi Fung GCF; Tam, Paul Kwong Hang PKH; Lau, Yu Lung YL; Tang, Clara Sze Man CSM; Yeung, Kit San KS; Chung, Brian Hon Yin BHY
Publication Date: 2021-02

Variant appearance in text: CFTR: 4046G>A; rs193922525
PubMed Link: 33600428
Variant Present in the following documents:
  • pgen.1009323.s003.xlsx, sheet 1
View BVdb publication page



New Therapeutic Approaches in Cystic Fibrosis.

Turkish Journal Of Pharmaceutical Sciences
Fakıoğlu, Dolunay Merve DM; Altun, Beril B
Publication Date: 2020-12-23

Variant appearance in text: CFTR: G1349D
PubMed Link: 33389985
Variant Present in the following documents:
  • Main text
View BVdb publication page



Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).

The Cochrane Database Of Systematic Reviews
Southern, Kevin W KW; Murphy, Jared J; Sinha, Ian P IP; Nevitt, Sarah J SJ
Publication Date: 2020-12-17

Variant appearance in text: CFTR: G1349D
PubMed Link: 33331662
Variant Present in the following documents:
  • Main text
View BVdb publication page



Novel therapeutic approaches for the management of cystic fibrosis.

Multidisciplinary Respiratory Medicine
Jaques, Ryan R; Shakeel, Arslan A; Hoyle, Cameron C
Publication Date: 2020-01-28

Variant appearance in text: CFTR: G1349D
PubMed Link: 33282281
Variant Present in the following documents:
  • Main text
  • mrm-15-1-690.pdf
View BVdb publication page



G970R-CFTR Mutation (c.2908G>C) Results Predominantly in a Splicing Defect.

Clinical And Translational Science
Fidler, Meredith C MC; Buckley, Alexandra A; Sullivan, James C JC; Statia, Marvin M; Boj, Sylvia F SF; Vries, Robert G J RGJ; Munck, Anne A; Higgins, Mark M; Moretto Zita, Matteo M; Negulescu, Paul P; van Goor, Fredrick F; De Boeck, Kris K
Publication Date: 2021-03

Variant appearance in text: CFTR: G1349D
PubMed Link: 33278322
Variant Present in the following documents:
  • Main text
View BVdb publication page



Current Treatment Options for Cystic Fibrosis-Related Liver Disease.

International Journal Of Molecular Sciences
Staufer, Katharina K
Publication Date: 2020-11-14

Variant appearance in text: CFTR: G1349D
PubMed Link: 33202578
Variant Present in the following documents:
  • Main text
  • ijms-21-08586.pdf
View BVdb publication page



Ivacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial.

American Journal Of Respiratory And Critical Care Medicine
Davies, Jane C JC; Wainwright, Claire E CE; Sawicki, Gregory S GS; Higgins, Mark N MN; Campbell, Daniel D; Harris, Christopher C; Panorchan, Paul P; Haseltine, Eric E; Tian, Simon S; Rosenfeld, Margaret M
Publication Date: 2021-03-01

Variant appearance in text: CFTR: G1349D
PubMed Link: 33023304
Variant Present in the following documents:
  • Main text
View BVdb publication page



Fluorescence assay for simultaneous quantification of CFTR ion-channel function and plasma membrane proximity.

The Journal Of Biological Chemistry
Prins, Stella S; Langron, Emily E; Hastings, Cato C; Hill, Emily J EJ; Stefan, Andra C AC; Griffin, Lewis D LD; Vergani, Paola P
Publication Date: 2020-12-04

Variant appearance in text: CFTR: G1349D
PubMed Link: 32934006
Variant Present in the following documents:
  • mmc1.pdf
View BVdb publication page



Pharmacogenetics: An Important Part of Drug Development with A Focus on Its Application.

International Journal Of Biomedical Investigation
Oates, J T JT; Lopez, D D
Publication Date: 2018

Variant appearance in text: CFTR: G1349D
PubMed Link: 32467882
Variant Present in the following documents:
  • Main text
  • nihms-1581346.pdf
View BVdb publication page



Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease.

Genes
Strub, Matthew D MD; McCray, Paul B PB
Publication Date: 2020-05-13

Variant appearance in text: CFTR: G1349D
PubMed Link: 32414011
Variant Present in the following documents:
  • Main text
View BVdb publication page



.

Emc. Pediatria
Noël, S S; Sermet-Gaudelus, I I
Publication Date: 2020-03

Variant appearance in text: CFTR: G1349D
PubMed Link: 32288518
Variant Present in the following documents:
  • main.pdf
View BVdb publication page



Emerging Cystic Fibrosis Transmembrane Conductance Regulator Modulators as New Drugs for Cystic Fibrosis: A Portrait of in Vitro Pharmacology and Clinical Translation.

Acs Pharmacology & Translational Science
Ghelani, Drishti P DP; Schneider-Futschik, Elena K EK
Publication Date: 2020-02-14

Variant appearance in text: CFTR: G1349D
PubMed Link: 32259083
Variant Present in the following documents:
  • Main text
View BVdb publication page



Abstracts from the 25th Italian Congress of Cystic Fibrosis and the 15th National Congress of Cystic Fibrosis Italian Society : Assago, Milan. 10 - 12 October 2019.

Italian Journal Of Pediatrics
Publication Date: 2020-04-01

Variant appearance in text: CFTR: G1349D
PubMed Link: 32234058
Variant Present in the following documents:
  • Main text
View BVdb publication page



CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine.

Frontiers In Pharmacology
Lopes-Pacheco, Miquéias M
Publication Date: 2019

Variant appearance in text: CFTR: G1349D
PubMed Link: 32153386
Variant Present in the following documents:
  • Main text
View BVdb publication page



Cost of precision medicine at a referral center for cystic fibrosis.

Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia
Marson, Fernando Augusto Lima FAL
Publication Date: 2020-03-02

Variant appearance in text: CFTR: G1349D
PubMed Link: 32130336
Variant Present in the following documents:
  • Main text
  • 1806-3713-jbpneu-46-02-e20190308.pdf
View BVdb publication page



Pediatric Orphan Drug Indications: 2010-2018.

Pediatrics
Kimmel, Lauren L; Conti, Rena M RM; Volerman, Anna A; Chua, Kao-Ping KP
Publication Date: 2020-04

Variant appearance in text: CFTR: G1349D
PubMed Link: 32127360
Variant Present in the following documents:
  • Main text
View BVdb publication page